Coronavirus disease 2019 (COVID-19) continues to burden society worldwide. Despite most
patients having a mild course, severe presentations have limited treatment options. COVID …

During the pandemic of severe respiratory distress syndrome coronavirus 2 (SARS-CoV2),
many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) …

The end of 2019 saw the beginning of the coronavirus disease 2019 (COVID-19) pandemic
that soared in 2020, affecting 215 countries worldwide, with no signs of abating. In an effort …

Since its eruption in China, novel coronavirus disease (COVID‐19) has been reported in
most of the countries and territories (> 200) of the world with∼ 18 million confirmed cases …

Since it was first reported, the novel coronavirus disease 2019 (COVID-19) remains an
unresolved puzzle for biomedical researchers in different fields. Various treatments, drugs …

Abstract Coronavirus disease 2019 (SARS-CoV2) is an active global health threat for which
treatments are desperately being sought. Even though most people infected experience mild …

Despite global efforts to establish effective interventions for coronavirus disease 2019
(COVID-19) and its major complications, such as acute respiratory distress syndrome …

Abstract The coronavirus disease 2019 (COVID-19) has been threatening the globe since
the end of November 2019. The disease revealed cracks in the health care system as health …

Currently, there are no specific and efficient vaccines or drugs for COVID-19, particularly in
severe cases. A wide range of variations in the clinical symptoms of different patients …

The COVID-19 pandemic has presented with debilitating respiratory consequences
especially more pronounced in high risk individuals. Individuals with underlying systemic …